Literature DB >> 87498

Serum cortisol levels of multiple sclerosis patients during ACTH treatment.

E Maida, K Summer.   

Abstract

The adrenocortical function in 52 multiple sclerosis patients was studied and compared to that of ten healthy control subjects. The basic secretion rate of cortisol of the MS patients was within the range of normal. Reactivity of the adrenal cortex to stimulation by synthetic ACTH was markedly reduced independent of the duration of the disease with the exception of four patients who were in an early stage of the disease. No difference could be demonstrated between patients undergoing a bout and patients in a stage of remission. The pathogenetic and prognostic significance of the results of the present study are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 87498     DOI: 10.1007/BF00313955

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

1.  ADRENOCORTICAL FUNCTION IN CHRONIC MALNUTRITION.

Authors:  J N COOKE; V H JAMES; J LANDON; V WYNN
Journal:  Br Med J       Date:  1964-03-14

2.  [On the problem of the function of the adrenal cortex in multiple sclerosis].

Authors:  M WENDER; J GUTOWSKI
Journal:  Wien Klin Wochenschr       Date:  1959-08-21       Impact factor: 1.704

3.  [Hormone status and the development of multiple sclerosis].

Authors:  W BIRKMAYER; H ISELSTOGER; D SEEMANN
Journal:  Klin Med Osterr Z Wiss Prakt Med       Date:  1955-12

4.  Adrenocortical function in multiple sclerosis.

Authors:  J A GARCIA-REYES; D JENKINS; P H FORSHAM; G W THORN
Journal:  AMA Arch Neurol Psychiatry       Date:  1952-12

5.  Adrenoleukodystrophy. A clinical and pathological study of 17 cases.

Authors:  H H Schaumburg; J M Powers; C S Raine; K Suzuki; E P Richardson
Journal:  Arch Neurol       Date:  1975-09

6.  Progressive spastic paraparesis and adrenal insufficiency.

Authors:  M Gumbinas; H M Liu; G Dawson; M Larsen; O Green
Journal:  Arch Neurol       Date:  1976-10

7.  Endocrine activity in multiple sclerosis.

Authors:  G M Teasdale; P A Smith; R Wilkinson; A L Latner; H Miller
Journal:  Lancet       Date:  1967-01-14       Impact factor: 79.321

8.  [Adrenalitis inclusio-necroticans in the Landry-Guillain-Barré-Syndrome].

Authors:  F W Spaar; H Orthner
Journal:  Dtsch Z Nervenheilkd       Date:  1968

9.  Visceral lesions in infectious polyneuritis: (Infectious neuronitis, acute polyneuritis with facial diplegia, guillain-barré syndrome, landry's paralysis).

Authors:  A B Sabin; C D Aring
Journal:  Am J Pathol       Date:  1941-07       Impact factor: 4.307

10.  Polyradiculoneuropathy in Addison's disease. Case report and review of literature.

Authors:  D H Abbas; R E Schlagenhauff; H E Strong
Journal:  Neurology       Date:  1977-05       Impact factor: 9.910

  10 in total
  3 in total

1.  Cyclic adenosine 3',5' monophosphate in cerebrospinal fluid of multiple sclerosis patients.

Authors:  E Maida; W Kristoferitsch
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

2.  Immunological treatment of multiple sclerosis.

Authors:  R A Hughes
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

3.  Acute and long-term effects of adrenocorticotropin and dexamethasone on the auditory brainstem response in multiple sclerosis patients.

Authors:  J Born; B Schwab; R Schwab; H Schreiber
Journal:  J Neurol       Date:  1993-12       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.